Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.

Crayne CB, Eloseily E, Mannion ML, Azerf SP, Weiser P, Beukelman T, Stoll ML, Feig DI, Prescott Atkinson T, Cron RQ.

Pediatr Rheumatol Online J. 2018 Nov 14;16(1):71. doi: 10.1186/s12969-018-0285-2. Review.

2.

Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis.

Crayne CB, Beukelman T.

Pediatr Clin North Am. 2018 Aug;65(4):657-674. doi: 10.1016/j.pcl.2018.03.005. Review.

PMID:
30031492
3.

Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis.

Stoll ML, Amin D, Powell KK, Poholek CH, Strait RH, Aban I, Beukelman T, Young DW, Cron RQ, Waite PD.

J Rheumatol. 2018 Aug;45(9):1301-1307. doi: 10.3899/jrheum.171306. Epub 2018 May 15.

PMID:
29764966
4.

Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.

Stoll ML, Grubbs JA, Beukelman T, Mannion ML, Jester TW, Cron RQ, Crain MJ.

Pediatr Rheumatol Online J. 2017 Nov 9;15(1):79. doi: 10.1186/s12969-017-0207-8.

5.

Biologic Agents in the Treatment of Childhood-Onset Rheumatic Disease.

Mehta J, Beukelman T.

J Pediatr. 2017 Oct;189:31-39. doi: 10.1016/j.jpeds.2017.06.041. Epub 2017 Jul 13. No abstract available.

PMID:
28711176
6.

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis.

Falvey S, Shipman L, Ilowite N, Beukelman T.

Pediatr Rheumatol Online J. 2017 Jun 19;15(1):52. doi: 10.1186/s12969-017-0180-2. Review.

7.

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.

Beukelman T, Anink J, Berntson L, Duffy C, Ellis JA, Glerup M, Guzman J, Horneff G, Kearsley-Fleet L, Klein A, Klotsche J, Magnusson B, Minden K, Munro JE, Niewerth M, Nordal E, Ruperto N, Santos MJ, Schanberg LE, Thomson W, van Suijlekom-Smit L, Wulffraat N, Hyrich K.

Pediatr Rheumatol Online J. 2017 Apr 19;15(1):31. doi: 10.1186/s12969-017-0161-5.

8.

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.

Beukelman T, Kimura Y, Ilowite NT, Mieszkalski K, Natter MD, Burrell G, Best B, Jones J, Schanberg LE; CARRA Registry Investigators.

Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30. doi: 10.1186/s12969-017-0160-6.

9.

The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.

Beukelman T, Xie F, Baddley JW, Chen L, Mannion ML, Saag KG, Zhang J, Curtis JR.

Arthritis Res Ther. 2016 Sep 22;18(1):210.

10.

Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients.

Mannion ML, Xie F, Baddley J, Chen L, Curtis JR, Saag K, Zhang J, Beukelman T.

Pediatr Rheumatol Online J. 2016 Sep 5;14(1):49. doi: 10.1186/s12969-016-0107-3.

11.

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

Zhang M, Bracaglia C, Prencipe G, Bemrich-Stolz CJ, Beukelman T, Dimmitt RA, Chatham WW, Zhang K, Li H, Walter MR, De Benedetti F, Grom AA, Cron RQ.

J Immunol. 2016 Mar 15;196(6):2492-503. doi: 10.4049/jimmunol.1501284. Epub 2016 Feb 15.

12.

Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.

Stoll ML, Vaid YN, Guleria S, Beukelman T, Waite PD, Cron RQ.

J Rheumatol. 2015 Nov;42(11):2155-9. doi: 10.3899/jrheum.150308. Epub 2015 Sep 1.

PMID:
26329345
13.

Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.

Tambralli A, Beukelman T, Cron RQ, Stoll ML.

J Rheumatol. 2015 Mar;42(3):541-6. doi: 10.3899/jrheum.140863. Epub 2015 Jan 15.

PMID:
25593242
14.

Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors.

Mannion ML, Xie F, Curtis JR, Beukelman T.

J Rheumatol. 2014 Oct;41(10):2078-84. doi: 10.3899/jrheum.140012. Epub 2014 Aug 1.

PMID:
25086081
15.

High doses of infliximab in the management of juvenile idiopathic arthritis.

Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML.

J Rheumatol. 2013 Oct;40(10):1749-55. doi: 10.3899/jrheum.130133. Epub 2013 Aug 15.

PMID:
23950184
16.

Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report.

Donnithorne KJ, Read RW, Lowe R, Weiser P, Cron RQ, Beukelman T.

Pediatr Rheumatol Online J. 2013 Jun 4;11(1):25. doi: 10.1186/1546-0096-11-25.

17.

Infectious complications in juvenile idiopathic arthritis.

Hurd A, Beukelman T.

Curr Rheumatol Rep. 2013 May;15(5):327. doi: 10.1007/s11926-013-0327-1. Review.

PMID:
23529583
18.

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.

Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG, Mannion ML, Patkar NM, Saag KG, Winthrop KL, Curtis JR; SABER Collaboration.

Arthritis Rheum. 2013 May;65(5):1384-9. doi: 10.1002/art.37866.

19.

What is the background incidence of malignancy in children with rheumatic disease?

Mannion ML, Beukelman T.

Curr Rheumatol Rep. 2013 Mar;15(3):310. doi: 10.1007/s11926-012-0310-2. Review.

PMID:
23378144
20.

Sarcoidosis in a young child with Alagille syndrome: a case report.

Mannion M, Zolak M, Kelly DR, Beukelman T, Cron RQ.

Pediatr Rheumatol Online J. 2012 Aug 31;10(1):32. doi: 10.1186/1546-0096-10-32.

Supplemental Content

Loading ...
Support Center